What: The U.S. Department of Veterans Affairs and Sanford Health will announce an initiative aimed at improving patient care and lowering costs related to adverse reactions to medications, which research shows costs up to $30 billion per year. The new program will reach 250,000 U.S. veterans at 125 sites by 2022.
Speakers:
- U.S. Department of Veterans Affairs Secretary Robert Wilkie
- Sanford Health CEO Kelby Krabbenhoft
- Deepak Voora, M.D., Director, Veterans Administration PHASeR Program, Associate Professor, Department of Medicine, Center for Applied Genomics & Precision Medicine, Duke University School of Medicine
Source: VA Secretary Robert Wilkie, Sanford Health CEO Kelby Krabbenhoft to announce major precision medicine partnership – National Press Club.
